Pages that link to "Q419935"
Jump to navigation
Jump to search
The following pages link to octreotide (Q419935):
Displaying 50 items.
- acromegaly (Q189580) (← links)
- pancreatic cancer (Q212961) (← links)
- carcinoid syndrome (Q339547) (← links)
- carcinoid tumor (Q1734755) (← links)
- neuroendocrine carcinoma (Q18554913) (← links)
- pituitary carcinoma (Q18556544) (← links)
- follicular adenoma (Q18557172) (← links)
- (Q11993289) (redirect page) (← links)
- In vitro characterization of somatostatin receptors in the human thymus and effects of somatostatin and octreotide on cultured thymic epithelial cells (Q22008658) (← links)
- Sporadic and genetic forms of paediatric somatotropinoma: a retrospective analysis of seven cases and a review of the literature (Q26825834) (← links)
- 10-(4-aminobutyl)-19-[(2-amino-3-phenylpropanoyl)amino]-16-benzyl-N-(1,3-dihydroxybutan-2-yl)-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide (Q27088142) (← links)
- The potential role of somatostatin analogues in breast cancer treatment (Q36988009) (← links)
- New medical therapies on the horizon: oral octreotide (Q39090289) (← links)
- Beau's lines after octreotide therapy (Q43249277) (← links)
- Graves' ophthalmopathy: diagnosis and highlights on etiopathogenesis and treatment (Q44469598) (← links)
- Octreotide in the treatment of acute gastrointestinal hemorrhage caused by ruptured esophageal varices (Q45247612) (← links)
- Hypophyseal thyrotropin adenomas at Yaounde (Cameroon). Analysis of two case reports: improvement with somatostatin analogue (SMS 201-995) (Q46547443) (← links)
- Sandostatin (Q47521925) (← links)
- Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices (Q61902285) (← links)
- The Longitudinal Approach to Acromegaly: A Pattern of Treatment and Comparative Effectiveness Research (Q61909453) (← links)
- Safety and Biological Activity of C2L-OCT-01 PR in Acromegalic Patients (Q61914732) (← links)
- GH, IGF-I and Somatostatin Analogues in Hepatocellular Carcinoma (Q61917535) (← links)
- AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors (Q61921358) (← links)
- Octreotide in Severe Polycystic Liver Disease (Q61921455) (← links)
- Efficacy/Safety of Octreotide Acetate in Patients With Uncontrolled Acromegaly (Q61932908) (← links)
- Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemotherapy (Q61934743) (← links)
- Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel (Q61955809) (← links)
- Imaging Malignant Glioma With 68Ga-DOTATOC PET/CT (Q61957362) (← links)
- A Multicenter Study Evaluating Efficacy and Safety of 177Lu-DOTA-TATE Based on Kidney-Dosimetry in Patients With Disseminated Neuroendocrine Tumors (Q61966086) (← links)
- Sandostatin for Patients With Androgen Independent Prostate Cancer (Q61979268) (← links)
- RAD001 Plus Octreotide Depot in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma (Q62104970) (← links)
- Study Comparing SOM230 Subcutaneously and Sandostatin Subcutaneously in Acromegalic Patients (Q62110170) (← links)
- Fludarabine Plus Octreotide in Treating Patients With Relapsed Low-Grade Non-Hodgkin's Lymphoma (Q62110203) (← links)
- Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer (Q62110336) (← links)
- Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast Cancer (Q62110669) (← links)
- Octreotide and Doxorubicin in Treating Patients With Advanced Cancer (Q62110980) (← links)
- Octreotide in the Prevention of Diarrhea in Patients Receiving Irinotecan for Metastatic Colon Cancer (Q62110982) (← links)
- Tolvaptan-Octreotide LAR Combination in ADPKD (Q62811791) (← links)
- Treatment Using 177Lu-DOTA-EB-TATE in Patients With Advanced Neuroendocrine Tumors (Q62812517) (← links)
- A Study of 18F-AlF-NOTA-octreotide PET/CT for Imaging Neuroendocrine Neoplasms (Q62820133) (← links)
- Terlipressin + Albumin Versus Midodrine + Octreotide in the Treatment of Hepatorenal Syndrome (Q63062596) (← links)
- A Study Comparing Treatment With 177Lu-DOTA0-Tyr3-Octreotate to Octreotide LAR in Patients With Inoperable, Progressive, Somatostatin Receptor Positive Midgut Carcinoid Tumours (Q63315542) (← links)
- Autologous Fibrin Glues for Fistulas Closure (Q63316401) (← links)
- Acromegaly Combination Treatment Study (Q63319666) (← links)
- Effects of Sandostatin LAR® in Acromegaly (Q63321557) (← links)
- Role of Octreotide in Preventing Pancreatic Fistula After Pancreaticoduodenectomy (PD) in Patients With Soft Pancreas (Q63337942) (← links)
- Long-term Safety and Efficacy Study of Octreotide Implant in Patients With Acromegaly (Q63339292) (← links)
- Whole Body Dynamic 68Ga-DOTATOC PET/CT in Neuroendocrine Tumors (Q63396224) (← links)
- A Four-Part Study to Assess the Safety, Tolerability, PK and PD of ONO-5788 in Healthy Adult Volunteers (Q63397309) (← links)
- Effect of Hyperglycemia on Microvascular Perfusion in Healthy Adults (Q63397504) (← links)